The FANCC gene helps repair DNA damage, especially in fast growing cells such as those in the bone marrow. This gene plays an important role in keeping blood making cells healthy and protecting the body as cells divide. When both copies of the FANCC gene do not work properly, a person can develop Fanconi anemia, which may cause low blood counts, easy bruising, frequent infections, slower growth, and a higher chance of some cancers.
What is a gene?
Genes are sections of DNA that provide cells with instructions to make molecules or direct processes in the body. Some genes carry the directions for producing proteins, the cell parts that do much of the work. Other genes mostly regulate the timing, place, and strength of certain processes. As a group, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
FANCCGene function
What if the gene works
The FANCC gene helps cells repair damaged DNA and cope with chemical stress. This supports healthy growth and is especially important for blood-forming cells and normal bone marrow function.
Risk
What if the gene does not work
More disruptive variants in the FANCC gene can cause Fanconi anemia, often with bone marrow failure, growth differences, and birth differences. Severity varies, and some people also have a higher chance of leukemia and certain solid cancers.
Treatment
What does that mean for your treatment
No FANCC-specific treatment or drug choice is currently established. Care for people with pathogenic variants in the FANCC gene follows general Fanconi anemia management rather than a plan chosen specifically for FANCC. The FANCC gene is being studied in gene therapy approaches for Fanconi anemia.
Conditions associated with FANCC
Gene function
What if the gene works
Your cells rely on the FANCC gene to protect DNA during everyday growth and cell division. It helps organize a repair response when DNA is under strain, especially while cells are copying their genetic material. This work supports steady cell turnover in tissues like the bone marrow, skin, and gut.
FANCC helps repair interstrand crosslinks (damage that ties the two DNA strands together). This is a central part of how the FANCC gene helps repair DNA in your cells.
FANCC helps send early repair signals so other proteins gather at the right spot. This coordination lets the repair process begin in an orderly way.
During cell division, FANCC helps cells handle blocks that appear while DNA is being copied. This supports smoother copying of the genetic instructions before a cell splits in two.
By supporting repair and DNA copying, FANCC helps keep genetic material stable over time. This steady job is especially useful in tissues that constantly make new cells, such as bone marrow and the gut lining.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the FANCC gene can weaken how the FANCC protein folds, stays stable, or joins the cell’s DNA repair team, which helps explain FANCC gene variant effects. Milder variants may leave some protein activity, while more severe variants, including truncating changes, can greatly reduce or stop protein production. This can disrupt repair signaling after DNA damage and, in people with Fanconi anemia, more severe variants may be linked to earlier or more pronounced features.
How variants are linked to conditions
Pathogenic variants in both copies of the FANCC gene cause Fanconi anemia, most often Fanconi anemia complementation group C. This inherited condition can include low blood counts from bone marrow failure, a higher chance of leukemia and some solid cancers, short stature, and differences present from birth. A confirmed pair of disease-causing FANCC variants can establish the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widespread across the population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link, not a firm diagnosis, particularly when more than one gene and environmental influences play a part. In other situations, though, one well-defined variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FANCC, risk is mainly shaped by the genetic change itself and whether one or both copies of the gene are affected in a family. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or lower FANCC-related risk.
Inheritance of FANCC variants
FANCC-related Fanconi anemia follows an autosomal recessive inheritance pattern. This means a child usually inherits one FANCC variant from each parent, and parents who carry one variant are often healthy carriers. When both parents carry a disease-causing FANCC variant, each pregnancy has a 25% chance of Fanconi anemia, a 50% chance of carrier status, and a 25% chance of inheriting neither variant. Because the FANCC gene is on chromosome 9, the FANCC inheritance pattern is the same for males and females.
What does my FANCC result mean for my family?
For FANCC, family members can sometimes carry the same changed gene even if they are healthy. Brothers and sisters may have the condition or be carriers, and parents are often carriers too. More distant relatives, such as aunts, uncles, and cousins, may also carry the change, so the result can matter for family planning across the wider family.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the FANCC gene, genetic testing usually uses a blood or saliva sample. A lab reads the DNA sequence and may also check for missing or extra pieces, which helps show whether a FANCC variant is present. FANCC genetic testing can confirm the genetic cause of Fanconi anemia in people with suggestive clinical findings.
When should I consider getting a genetic test?
Genetic testing for the FANCC gene is worth considering when someone has signs of Fanconi anemia, such as low blood counts, poor growth, or certain birth differences. It can also help if a close relative has a harmful FANCC change, or if both partners want to understand their chance of having a child with this condition.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals varies by the condition and the type of variant involved. Over time, many other factors, including lifestyle, environment, age, and medical history, also influence how the body works. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences affect a person’s response to medications. It examines links between genes and drugs to understand why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the FANCC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about side effects, new symptoms, or how a medicine may affect you are best discussed with your doctor. FANCC has been studied because changes in it can affect how cells respond to some cancer medicines that damage DNA, but this is not a routine guide for prescribing.
History
Throughout history, people have described features that hinted at this gene. Fanconi anemia was first described in 1927 by the Swiss pediatrician Guido Fanconi, long before its genetic causes were known. In the late 1980s and early 1990s, researchers showed that the condition was genetically diverse, with different family groups linked to different genes. Building on this early work, scientists identified the FANCC gene in 1992, a major step in sorting Fanconi anemia into distinct genetic types. That discovery helped clarify why people with the same diagnosis could have different inherited changes. Over time, the FANCC gene became part of the broader story of how inherited bone marrow conditions were mapped at the DNA level.